CBAY
Cymabay Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
cymabay therapeutics is a clinical-stage biopharmaceutical company located in the san francisco bay area focused on developing therapies to treat metabolic diseases with high unmet medical need or serious rare and orphan diseases. we are committed to developing breakthrough medicines that improve the lives of patients and their families. cymabay was seeded with the assets from an earlier metabolic disease company in which more than $120m was invested to produce a robust pipeline.
Market Cap: 3.7 Billion
Primary Exchange: NASDAQ
Website: http://www.cymabay.com/
Shares Outstanding: 115 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.2330617719123094
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 1802 trading days
From: 2018-03-02 To: 2023-09-07
Lowest Point:
SYBX, MAT among premarket gainers
via: SeekingAlpha at 2019-06-12 05:16:31:000
Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more … read more...
SYBX, MAT among premarket gainers
via: SeekingAlpha at 2019-06-12 05:16:31:000
Synlogic (NASDAQ: SYBX ) +26% as Ginkgo Bioworks to invest $80M . More news on: Synlogic, Inc., Bridgeline Digital, Inc., MagnaChip Semiconductor Corporation, , Stocks on the move Read more … read more...
CymaBay +4.8% as Raymond James fades 45% sell-off
via: SeekingAlpha at 2019-06-11 13:32:35:000
Raymond James has upgraded CymaBay Therapeutics (NASDAQ: CBAY ) to Strong Buy after today's harsh market reaction to experimental data released this morning. More news on: CymaBay Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Healthcare tops midday movers
via: SeekingAlpha at 2019-06-11 08:41:05:000
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1… read more...
HDS, SYMC and BYND among premarket losers
via: SeekingAlpha at 2019-06-11 05:16:59:000
CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more … read more...
CymaBay down 40% premarket on disappointing data on NASH candidate seladelpar
via: SeekingAlpha at 2019-06-11 03:29:58:000
CymaBay Therapeutics (NASDAQ: CBAY ) craters 40% premarket on light volume (so far) in reaction to 12-week data from a Phase 2b clinical trial evaluating seladelpar in patients with nonalcoholic steatohepatitis (NASH). More news on: CymaBay Therapeutics, Inc., Healthcare st… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|